Precision BioSciences, Inc. (DTIL) — Stock Score Summary

Precision BioSciences, Inc. (DTIL) has a MoatMap StockRank of 54/100 based on Quality (35/100), Value (41/100), and Momentum (65/100) factor scores. The current signal is HOLD. Precision BioSciences is a micro-cap gene editing biotech. It is highly speculative, pre-revenue, and lacks the established business model, cash flows, and margin of safety required for our portfolio.

Precision BioSciences, Inc. is a clinical-stage biotechnology company developing gene editing therapies using its proprietary ARCUS® platform. The company's focus includes allogeneic CAR T immunotherapies for cancer, in vivo gene editing for genetic diseases, and ex vivo gene editing for gene and cell therapy. Precision BioSciences' strength lies in its differentiated gene editing technology and its potential to address a wide range of therapeutic indications.

Key Financial Metrics

Price$6.86
Market Cap$179M
P/E (Forward)-3.35
Price/Book2.17
Return on Equity-70.9%
Return on Invested Capital-31.1%
Debt/Equity37.41
Gross Margin100.0%
Operating Margin-83.7%
Revenue Growth37272.4%
Free Cash Flow$-22M

Precision BioSciences, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Precision BioSciences, Inc.’s (DTIL) StockRank?
MoatMap’s StockRank for Precision BioSciences, Inc. (DTIL) is 54/100, with a Hold signal. It is a composite of Quality (35), Value (41), and Momentum (65) factor ranks across MoatMap’s 19,000+ stock universe.
Does Precision BioSciences, Inc. have an economic moat?
Precision BioSciences, Inc. (DTIL) has a Quality factor score of 35/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Precision BioSciences, Inc. a buy, hold, or sell?
MoatMap’s current signal for Precision BioSciences, Inc. (DTIL) is Hold, based on a StockRank of 54/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Precision BioSciences, Inc. in?
Precision BioSciences, Inc. (DTIL) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksDTIL deep dive reportAI ChampionsHow we score stocksSense-check another stock